44.13 Risk stratification using PT-INR to albumin ratio in patients with hepatocellular carcinoma

K. Haruki1, H. Shiba1, N. Saito1, T. Horiuchi1, Y. Shirai1, Y. Fujiwara1, K. Furukawa1, T. Sakamoto1, T. Gocho1, T. Misawa1, K. Yanaga1  1The Jikei University School Of Medicine,Department Of Surgery,Tokyo, TOKYO, Japan

Introduction:  Liver function in patients with hepatocellular carcinoma (HCC) is generally graded according to the Child-Pugh (C-P) system.  However, some variables in the C-P grade are subjective.  We developed a novel objective score; prothrombin time-international normalized ratio to albumin ratio (PTAR).  The aim of this study is to evaluate the prognostic value of PTAR in patients with HCC after hepatic resection.

Methods:  The study comprised 199 patients who had undergone elective hepatic resection for HCC between January 2003 and December 2014.  We retrospectively investigated the relation between PTAR and disease-free as well as overall survival and assessed hepatic functional reserve using the PTAR in comparison with C-P grade.

Results: The optimal cut-off level of the PTAR was 0.288.  In multivariate analysis, the independent and significant predictors of cancer recurrence consisted of HCV infection (p=0.011), pT4 or pT3 (p<0.001) and PTAR ≥ 0.0288 (p=0.024), while the independent and significant predictors of poor overall survival were pT4 or pT3 (p<0.001) and PTAR ≥ 0.0288 (p<0.001).  ICGR15 (p=0.007), C-P score (p<0.001) and serum AFP (p=0.037) positively correlated with high PTAR.  Pathological liver cirrhosis (p<0.001), postoperative ascites (p=0.039) and postoperative liver failure (p=0.040) in patients with high PTAR were significantly greater than their counterparts.  In patients with C-P grade A, PTAR ≥ 0.0288 was significantly associated with worse disease-free survival (p=0.024) and overall survival (p=0.030).

Conclusion: The PTAR may be an independent and significant indicator of poor long-term outcome in patients with HCC after hepatic resection.  The PTAR may reflect liver function, and patients with C-P grade A could be stratified by the PTAR.